By Julie Steenhuysen CHICAGO (Reuters) - A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with advanced melanoma in an early-stage study, U.S. researchers said on Sunday. The findings on the melanoma drug lambrolizumab were published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology meeting in Chicago this weekend. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment